Skip to content

Breast reconstruction: differences in outcome between two types of breast implants?

Long-term results of two-stage breast reconstruction with polyurethane-covered versus textured implants: a prospective, multicenter randomized controlled trial

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON29142
Enrollment
321
Registered
2018-06-09
Start date
2019-02-25
Completion date
Unknown
Last updated
2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Breast reconstruction

Interventions

Patients in both cohorts will receive a two-stage implant-based breast reconstruction after mastectomy. In the second stage, the intervention cohort will receive a polyurethane covered silicone implan

Sponsors

Erasmus MC
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: • Female • Age of 18 years or older • Mastectomy is performed • Eligible for two-stage implant-based breast reconstruction in accordance with the Dutch national breast reconstruction guideline • First step of two-stage implant-based breast reconstruction (placement of tissue expander) is successfully completed • Able to understand the patient information sheet, to complete questionnaires and to provide written informed consent

Exclusion criteria

Exclusion criteria: • Additional use of autologous tissues for the breast reconstruction • The use of acellular dermal matrix or synthetic mesh • Prior irradiation of the breast or an indication for postoperative radiotherapy • Revision surgery or tertiary breast reconstruction • Inflammatory carcinoma • Evidence of distant metastases • Active infection at the surgical field or distant locations

Design outcomes

Primary

MeasureTime frame
capsular contracture rate

Secondary

MeasureTime frame
revision surgery rates, complication rates, patient satisfaction and quality of life, user friendliness

Contacts

Public ContactXavier Harmeling

Postbus 2040, 3000 CA Rotterdam, intern postadres Ee-15.89

tipi@erasmusmc.nl+31107043242

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)